Next-Gen BI for Healthcare and Life Sciences on AWS

Healthcare and Life Sciences organizations are using data to generate knowledge that helps them provide better patient care, enhances biopharma research and development, and streamlines operations across the product innovation and care delivery continuum. Next-Gen business intelligence (BI) solutions can help organizations reduce time-to-insight by aggregating and analyzing structured and unstructured data sets in real or near-real time.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Onco hu mice for evaluation of immuno-oncology therapeutics

Jax

Join this webinar to learn about cutting edge preclinical mouse platforms used to evaluate immuno-modulatory therapies for human cancer. Discussion topics include
Watch Now

The centerpiece of biosimilar adoption

Biosimilars have the potential to deliver significant cost savings across healthcare. As this emerging market evolves, the product landscape faces significant hurdles. In order to ensure success
Watch Now

Realising the recurrent savings and associated benefits of digital healthcare

Healthcare Financial Management Association (HFMA)

Following the ‘Delivering the benefits of digital healthcare’ the role of Transformation teams has become central to cutting costs whilst improving efficiency One of the reports key lessons was, “A transformation programme supported by technology is needed, not the other way round. This is the fundamental lesson that underpins everything else.” Winscribe and the Bloor Research team have come together to demonstrate how assessing a trust’s clinical correspondence processes against best practice, bench-marking & industry standard maturity model practices can highlight additional, significant recurrent savings.
Watch Now

Are You Ready for EKRA? What You Need to Know Now About How this New Legislation Affects Your Lab

darkdaily

As written, however, EKRA is far more expansive with its broad language enabling the federal government to monitor provider arrangements intended to generate business for any laboratory services, not just those related to individuals in treatment for substance abuse disorders, payable by a FHCP or commercial health insurer.
Watch Now